Oncogenic functions for METTL14 have been suggested in several cancer types, including pancreatic, breast and AML (Weng et al., 2018; Paris et al., 2019; Wang et al., 2020a; Kong et al., 2020; Yi et al., 2020). This evidence concerns the gene METTL14 and acute myeloid leukemia.